Holmium Laser for Reversal of Cerebral Artery Vasospasm

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 29540	Program Year/Program: 1997 / SBIR
Agency Tracking Number: 29540	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: SCHWARTZ ELECTRO-OPTICS, INC.
3404 N. Orange Blossom Trail Orlando, FL 32804
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 1997

Title: Holmium Laser for Reversal of Cerebral Artery Vasospasm

Agency: HHS

Contract: 1 R43 HL54398-01,

Award Amount: $687,478.00

Abstract:
Cerebral artery vasospasm may occur in patients suffering from subarachnoid hemorrhage and can resuneurological damage. The number of patients suffering from cerebral vasospasm is in excess of 20,000often produces permanently crippling effects or death in the 30-40 year old age group that exhibitspresent, there is no FDA approved procedure that is capable of permanently dilating the cerebral artbased treatment developed at Massachusetts General Hospital has been shown to reverse cerebral artercanine model. The goal of this Phase I effort will be to measure vasodilation as a function of laserex-vivo, living dog cerebral arteries in spasm. In Phase II, clinical testing would be started in orfavorable results observed in the canine model apply to humans. The long-term goal of the project woFDA approved laser system with fiber-optic delivery that would prevent the crippling effects of this

Principal Investigator:
Peter Moulton
40798

Business Contact:

Small Business Information at Submission:

Schwartz Electro-optics, Inc.
3404 N Orange Blossom Trail Orlando, FL 32804

EIN/Tax ID:

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No